Liposomal SunActive iron versus conventional iron in the treatment of iron deficiency anemia in children aged 2-12 years: A prospective, randomized controlled trial

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202408587364621

Enrollment

192

Registered

2024-08-21

Start date

2023-01-03

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders

Interventions

Oral Liposomal Sunactive.

Oral Traditional iron

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with iron deficiency anemia Age of children were from 2-12 years

Exclusion criteria

Exclusion criteria: Children with other types of anemias Patients with Celiac disease Patients who refused to sign the informed consent

Design outcomes

Primary

Measure	Time frame
Response of oral iron therapy after one month post intervention by increased hemoglobin level, hematocrit and serum ferritin	—

Secondary

Measure	Time frame
Response of oral iron therapy after 6 months post intervention by improvement of anthropometric measurements of growth	—

Countries

Egypt

Contacts

Public ContactAsmaa Mahmoud

Associate professor of pediatrics

asmaasolima50@gmail.com002701060408035

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026